This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
Favorite
2017
This tool is designed to help clinicians select adults for LTBI testing who are at high-risk for TB exposure or progression to TB disease. The tool calls out 3 groups for testing: foreign-born; immunosuppressed (e.g., HIV, TNF alpha inhibitor use, steroids, organ transplant); and contacts.
Favorite
2017
This website provides information regarding TB and migration issues.
Favorite
International Agencies
2017
The BCG World Atlas is a database of policies and practices of the Bacillus Calmette-Guérin (BCG) vaccine from countries all over the world.
Variations in BCG vaccination practices impact the interpretation of TB diagnostics, such as the widely used Tuberculin Skin Test (TST). This tool can assist clinicians in making diagnostic decisions concerning TB infection.
Favorite
Civil Surgeons
2017
This series covers six topics —TB disease, TB infection, tuberculin skin testing, TB contact investigation, TB and HIV coinfection, and TB medicine. The materials are in English (low literacy), Spanish with English translation, Tagalog with English translation, and Vietnamese with English translation.
Favorite
Non-U.S.-born persons
Persons With LTBI
2017
This 2-page document covers the basics of when TB skin tests are recommended, how TB is spread, what active TB disease and latent TB infection is, and what getting a TB skin test entails.
Favorite
General Public
2017
This 75-minute webinar provides information on how to put together results from conventional growth-based and molecular methods of TB drug susceptibility testing (including conflicting or contradictory results) to request further testing and/or design optimal treatment regimens for TB patients.
Favorite
Lab Personnel
Nurses
Physicians
2017
This infographic provides information to the public about TB and diabetes.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2017
This infographic highlights information on TB and diabetes.
Favorite
Health Educators/Communicators
2017
This fact sheet describes Bovine tuberculosis. The resource includes information on how bovine TB is transmitted to humans, symptoms of bovine TB, how bovine TB is diagnosed and treated, and how to decrease chances of getting bovine TB.
Favorite
General Public
2017
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2016.
Favorite
Policy Makers
2017
This pocket guide is intended to assist clinicians in managing HIV-infected patients with LTBI and drug-susceptible active pulmonary TB. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.
Favorite
Persons with TB
2016
A fact sheet on the TB skin test, including information on latent TB infection, TB disease, and what a positive/negative skin test means. The fact sheet also has information on testing after receiving the BCG vaccine.
Favorite
Health Educators/Communicators
Outreach Workers
2016
A fact sheet on the QuantiFERON (also called QFT test), including information on how test results are interpreted. There is also content on the difference between latent TB infection and TB disease.
Favorite
Health Educators/Communicators
Outreach Workers
2016
This manual is a joint publication of the Curry International TB Center and the Tuberculosis Control Branch of the California Department of Public Health. The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.
Favorite
2016
This webinar includes a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat latent TB infection (LTBI).
Favorite
2016
This pamphlet explains TB transmission, the difference between latent TB infection (LTBI) and TB disease, and the treatment for LTBI.
Favorite
Persons With LTBI
2016
This document is a compilation of survivor stories that feature the personal journeys of 15 individuals who have fought against TB disease.
Favorite
Policy Makers
2016
This fact sheet provides information on the connection between TB and diabetes and outlines activities where TB and diabetes programs can collaborate.
Favorite
2016
This document highlights how the Ministries of Health of the 30 highest TB burden countries, and their partners, are beginning to adopt, adapt and implement the End TB Strategy.
Favorite
2016
